CLPT
ClearPoint Neuro Inc

3,229
Mkt Cap
$372.63M
Volume
349,422.00
52W High
$30.10
52W Low
$9.76
PE Ratio
-15.87
CLPT Fundamentals
Price
$12.98
Prev Close
$13.11
Open
$13.07
50D MA
$19.89
Beta
2.00
Avg. Volume
998,109.37
EPS (Annual)
-$0.6998
P/B
23.48
Rev/Employee
$272,956.52
Loading...
Loading...
News
all
press releases
Geode Capital Management LLC Buys 323,429 Shares of ClearPoint Neuro, Inc. $CLPT
Geode Capital Management LLC increased its position in ClearPoint Neuro, Inc. (NASDAQ:CLPT - Free Report) by 107.3% in the second quarter, according to its most recent disclosure with the Securities...
MarketBeat·5d ago
News Placeholder
More News
News Placeholder
ClearPoint Neuro (NASDAQ:CLPT) Cut to Sell at Wall Street Zen
Wall Street Zen cut ClearPoint Neuro from a "hold" rating to a "sell" rating in a research report on Saturday...
MarketBeat·25d ago
News Placeholder
ClearPoint Neuro, Inc. (CLPT) Reports Q3 Loss, Lags Revenue Estimates
ClearPoint Neuro (CLPT) delivered earnings and revenue surprises of -5.00% and -10.50%, respectively, for the quarter ended September 2025. Do the numbers hold clues to what lies ahead for the stock?
Zacks·1mo ago
News Placeholder
Pacific Biosciences of California (PACB) Reports Q3 Loss, Lags Revenue Estimates
Pacific Biosciences (PACB) delivered earnings and revenue surprises of +25.00% and -3.51%, respectively, for the quarter ended September 2025. Do the numbers hold clues to what lies ahead for the stock?
Zacks·1mo ago
News Placeholder
Integra LifeSciences (IART) Q3 Earnings Beat Estimates
Integra (IART) delivered earnings and revenue surprises of +25.58% and -3.07%, respectively, for the quarter ended September 2025. Do the numbers hold clues to what lies ahead for the stock?
Zacks·1mo ago
News Placeholder
TransMedics (TMDX) Beats Q3 Earnings Estimates
TransMedics (TMDX) delivered earnings and revenue surprises of +78.38% and -0.76%, respectively, for the quarter ended September 2025. Do the numbers hold clues to what lies ahead for the stock?
Zacks·1mo ago
News Placeholder
CLPT Expands Into Robotic System Supporting Cell and Gene Therapies
ClearPoint's new Robotic Neuro-Navigation System merges proven software with KUKA robotics to boost precision in cell and gene therapy delivery.
Zacks·2mo ago
News Placeholder
ClearPoint Neuro, Inc. (CLPT) Reports Q2 Loss, Misses Revenue Estimates
ClearPoint Neuro (CLPT) delivered earnings and revenue surprises of -5.00% and -3.00%, respectively, for the quarter ended June 2025. Do the numbers hold clues to what lies ahead for the stock?
Zacks·4mo ago
News Placeholder
RxSight, Inc. (RXST) Reports Q2 Loss, Beats Revenue Estimates
RxSight (RXST) delivered earnings and revenue surprises of +20.00% and +0.11%, respectively, for the quarter ended June 2025. Do the numbers hold clues to what lies ahead for the stock?
Zacks·4mo ago
News Placeholder
5 High-Flying Medical Instrument Stocks to Buy Despite Recent Turmoil
Zacks·7mo ago

Latest CLPT News

View

Advertisement|Remove ads.

Advertisement|Remove ads.